Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of UY27698A1publicationCriticalpatent/UY27698A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención revela compuestos correspondientes a la fórmula en donde A, R, X, Y, R, R1, Y R2 son tal como se definen, formulaciones farmacéuticas, métodos de fabricación y usos de los mismos en el tratamiento de enfermedades mediadas por la quinasa p38.The present invention discloses compounds corresponding to the formula wherein A, R, X, Y, R, R1, and R2 are as defined, pharmaceutical formulations, manufacturing methods and uses thereof in the treatment of diseases mediated by p38 kinase.
UY27698A2002-03-072003-03-06
BICYCLE PYRIMIDINE AND PYRIDINE INHIBITORS OF QUINASA.
UY27698A1
(en)
Compounds derived from [1,2,4] triazolo [1,5-a] pyridine, jak inhibitors; pharmaceutical composition; pharmaceutical kit; its use in the treatment of diseases such as cancer, diabetes, Alzheimer's disease, liver disease, CNS disorders, among others.
DERIVATIVES OF N- (HETERO) ARIL-PIRROLIDINA DE PIRAZO-4-IL-PIRROLO [2,3-D] PIRIMIDINES AND PIRROL-3-IL-PIRROLO [2,3-D] PYRIMIDINES AS IHNIBITORS OF THE JANUS KINASE